Oct 17, 2013 ... Susan Halabi, <sup>corresponding author</sup> .... safety of satraplatin plus prednisone vs
placebo plus prednisone in men with mCRPC who were .... Armstrong et al.
developed and validated a prognostic model of OS in men who failed ...
Sep 27, 2014 ... Reanalyzing data from a previously randomized trial, Halabi et al have ... failure (
∼8 months before docetaxel vs ∼3 months post-docetaxel).
He et al.  were able to isolate CTCs this way and observed that 10 of 13 PC
patients had a ..... The v-ets erythroblastosis virus E26 oncogene homolog, ERG,
is a ..... Murray NP, Reyes E, Badinez L, Orellana N, Fuentealba C, Olivares R, et
al. ... Armstrong AJ, Shen T, Halabi S, Kemeny G, Bitting RL, Kartcheske P, et al.
Expression of E gene was abolished as previously described (DeDiego et al.,
2007). ..... The cDNAs were amplified by PCR using sense primers SARS-25211-
VS ..... H.P. Jia, C. Halabi, C.D. Sigmund, D.K. Meyerholz, P. Kirby, D.C. Look, S.
Perlman ... Pewe et al., 2005; L. Pewe, H. Zhou, J. Netland, C. Tangudu, H.
Jul 1, 2015 ... Hamalainen A, Tervo S, Grau-Olivares M, Niskanen E, Pennanen C, Huuskonen
J, et al. ... Halabi C, Halabi A, Dean DL, Wang PN, Boxer AL, Trojanowski JQ, et
al. ... in Parkinson's disease versus behavioural variant frontotemporal ....
Rueckert D, Sonoda LI, Hayes C, Hill DL, Leach MO, Hose DR, et al.
vasculature (inhibition of angiogenesis) by inhibiting V-RAF murine sarcoma viral
oncogene ... Boutan-Laroze A, Mahjoubi M, Droz JP et al. .... Olivares J, Hyman
W, Senzer N et al. A phase II trial ... Phillips G, Sanford D, Halabi S et al. Phase II
I started by building a model based using the initial selection of variables used by
Halabi et al. in their work, plus a number of obviously related or potentially ...